Evidence map›Paper›PMID 41986346›Full record

ArticleNature communications2026

Shared structural mechanisms of alternating access between the secondary peptide transporter SbmA and ABC transporters.

Thijs W Ettema, Satomi Inaba-Inoue, Chancievan Thangaratnarajah, Leticia Alves da Silva, Nikas Senning, Amy Clarke, Piotr Stepien, Anokhi Shah, Yue Ma, Katie Hardman and 11 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. BacA(SbmA) importer of legume symbiotic NCR peptides: Protein architecture, function, and evolutionary implications.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Thijs W Ettema *Membrane Enzymology Group, Groningen, Biomolecular Sciences and Biotechnology, Faculty of Science and Engineering, University of Groningen, Groningen, The Netherlands.ORCID http://orcid.org/0009-0006-3946-0356
Satomi Inaba-Inoue *Department of Life Sciences, Imperial College London, London, UK.ORCID http://orcid.org/0000-0002-6939-1324
Chancievan Thangaratnarajah *Membrane Enzymology Group, Groningen, Biomolecular Sciences and Biotechnology, Faculty of Science and Engineering, University of Groningen, Groningen, The Netherlands.ORCID http://orcid.org/0000-0002-0279-6642
Leticia Alves da SilvaInstitute of Pharmacology, Medical University of Vienna, Vienna, Austria.
Nikas SenningInstitute of Pharmacology, Medical University of Vienna, Vienna, Austria.ORCID http://orcid.org/0009-0004-5628-0010
Amy ClarkeInstitute of Pharmacology, Medical University of Vienna, Vienna, Austria.ORCID http://orcid.org/0009-0006-1319-1311
Piotr StepienMalopolska Centre of Biotechnology, Jagiellonian University, Krakow, Poland.ORCID http://orcid.org/0000-0002-4859-6443
Anokhi ShahBioEmPiRe Centre for Structural Biological EPR Spectroscopy, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.ORCID http://orcid.org/0000-0001-9818-5573
Yue MaBioEmPiRe Centre for Structural Biological EPR Spectroscopy, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.ORCID http://orcid.org/0000-0001-5934-0497
Katie HardmanAstbury Centre for Structural Molecular Biology, School of Biomedical Sciences, University of Leeds, Leeds, UK.ORCID http://orcid.org/0000-0003-3536-8027
Sophia DavidCentre for Genomic Pathogen Surveillance, Pandemic Sciences Institute, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0002-0115-0954
Hassane El MkamiSchool of Physics and Astronomy, University of St. Andrews, St. Andrews, UK.ORCID http://orcid.org/0000-0002-0552-5784
Jonathan G HeddleMalopolska Centre of Biotechnology, Jagiellonian University, Krakow, Poland.ORCID http://orcid.org/0000-0003-0994-9928
Norimichi NomuraDepartment of Cell Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.ORCID http://orcid.org/0000-0002-6330-2239
Satoshi OgasawaraDepartment of Cell Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.ORCID http://orcid.org/0000-0001-6908-9953
So IwataDepartment of Cell Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.ORCID http://orcid.org/0000-0003-1735-2937
Dmitry GhilarovMalopolska Centre of Biotechnology, Jagiellonian University, Krakow, Poland. dmitry.ghilarov@bioch.ox.ac.uk.ORCID http://orcid.org/0000-0001-9325-3207
Christos PliotasBioEmPiRe Centre for Structural Biological EPR Spectroscopy, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK. christos.pliotas@manchester.ac.uk.ORCID http://orcid.org/0000-0002-4309-4858
Thomas StocknerInstitute of Pharmacology, Medical University of Vienna, Vienna, Austria. thomas.stockner@meduniwien.ac.at.ORCID http://orcid.org/0000-0002-7071-8283
Dirk J SlotboomMembrane Enzymology Group, Groningen, Biomolecular Sciences and Biotechnology, Faculty of Science and Engineering, University of Groningen, Groningen, The Netherlands. d.j.slotboom@rug.nl.ORCID http://orcid.org/0000-0002-5804-9689
Konstantinos BeisDepartment of Life Sciences, Imperial College London, London, UK. kbeis@imperial.ac.uk.ORCID http://orcid.org/0000-0001-5727-4721

Funding

Gates Foundation INV-025280Japan Society for the Promotion of Science London (JSPS London) 24K08708RCUK | Biotechnology and Biological Sciences Research Council (BBSRC) BB/H01778X/1RCUK | Biotechnology and Biological Sciences Research Council (BBSRC) BB/S018069/1bbsRCUK | Biotechnology and Biological Sciences Research Council (BBSRC) BB/T006048/1RCUK | Biotechnology and Biological Sciences Research Council (BBSRC) BB/W019795/1RCUK | Biotechnology and Biological Sciences Research Council (BBSRC) BB/X01097X/1
6 · The paper itself

Abstract

SbmA is a membrane transporter from Escherichia coli that imports antimicrobial peptides. SbmA belongs to the SbmA-like peptide transporter (SLiPT) family. Although the protein is a secondary active transporter that is energized by the proton gradient, it is structurally related to the transmembrane domain (TMD) of ATP-binding cassette (ABC) transporters. SbmA therefore bridges the structural divide between primary and secondary transporters. However, it remains unclear, if SbmA also shares the mechanism of alternating access with ABC transporters, because only a single (outward-open) state is resolved. Here, we show by sequence analysis that SbmA is likely evolved from the TMD of an early ancestor of the ABC transporter YddA. We determine the cryogenic electron microscopy structures of SbmA in occluded and inward-facing states. These conformations closely resemble equivalent states found in ABC transporters, indicating a shared structural mechanism of transport. In contrast to ABC transporters, where nucleotide binding, hydrolysis and release steer conformational changes necessary for substrate translocation, electron paramagnetic resonance (EPR) spectroscopy and molecular dynamics (MD) simulations reveal how pH changes induce conformational transitions in SbmA, consistent with a mechanism of substrate internalization that utilizes the transmembrane proton gradient.

Indexed as

ATP-Binding Cassette TransportersEscherichia coliEscherichia coli ProteinsMembrane Transport ProteinsCryoelectron MicroscopyElectron Spin Resonance SpectroscopyMolecular Dynamics SimulationProtein ConformationATP-Binding Cassette TransportersEscherichia coli ProteinsMembrane Transport Proteins

Identifiers

PMID41986346
PMCPMC13316013

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.